@article{ATM29030,
author = {Christelle de la Fouchardiere},
title = {Treating BRAFV600E metastatic colorectal patients in 2019: a BEACON of hope?},
journal = {Annals of Translational Medicine},
volume = {7},
number = {21},
year = {2019},
keywords = {},
abstract = {BRAF V600E mutations have been described, since their discovery date in 2002, in about 10% of metastatic colorectal (mCRC) patients (pts) included in prospective clinical trials or retrospective studies (1-3). However, this rate could have been underestimated as suggested in a prospective population-based cohort and confronted by clinical observations (4,5).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/29030}
}